1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular and clinical landscape of CNS tumors arising among adolescents and young adults (AYA) at Memorial Sloan Kettering Cancer Center (MSKCC): A single-institutional experience
    Meeting Abstract

    Li, B. K.; Miller, A.; Bouvier, N.; Hill, K.; Berger, M. F.; Sait, S. F.; Karajannis, M.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • A novel epigenetic nanotherapeutic strategy to induce medulloblastoma differentiation
    Meeting Abstract

    Raju, P.; Tylawsky, D.; Vaynshteyn, J.; Gerwin, J.; Heller, D.; Snuderl, M.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Long-term survival from a phase 1 doseescalation trial using convection-enhanced delivery (CED) of radioimmunotherapeutic (124)I-omburtamab for treatment of diffuse intrinsic pontine glioma (DIPG)
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Tasker, N.; Haque, S.; Zanzonico, P.; Carrasquillo, J.; Lyashchenko, S. K.; Thakur, S. B.; Khakoo, Y.; Dunkel, I. J.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • AKT inhibition as a therapeutic strategy to constrain histological transdifferentiation in EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Rekhtman, N.; Houck-Loomis, B.; Koche, R. P.; Yu, H. A.; Sen, T.; Rudin, C. M.
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Circulating tumor DNA to identify genomic biomarkers of radiation sensitivity in locally advanced non-small cell lung cancer
    Meeting Abstract

    Lebow, E.; Li, B. T.; Sheverdian, N.; Eichholz, J.; Kratochvil, L. B.; Gelblum, D. Y.; Simone, C. B. 2nd; Shepherd, A. F.; Shin, J. Y.; Rimner, A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • TA0953/HM06, a novel RET-specific inhibitor effective in extracranial and CNS disease models of NSCLC with RETfusions
    Meeting Abstract

    Odintsov, I.; Lui, A. J. W.; Delasos, L.; Khodos, I.; Chang, Q.; Mattar, M. S.; Vojnic, M.; Lu, Y. C.; Kunte, S.; Bonifacio, A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • First-line pembrolizumab or placebo combined with etoposide and platinum for ES-SCLC: KEYNOTE-604 long-term follow-up results
    Meeting Abstract

    Rudin, C. M.; Kim, H. R.; Navarro, A.; Gottfried, M.; Peters, S.; Csőszi, T.; Cheema, P. K.; Rodriguez-Abreu, D.; Wollner, M.; Czyżewicz, G.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Brain metastasis—A distinct oncologic disease best served by an integrated multidisciplinary team approach
    Editorial

    Moss, N. S.; Beal, K.; Tabar, V.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • The dynamic mutational landscape of cerebrospinal fluid circulating tumor DNA can predict survival after proton craniospinal irradiation for leptomeningeal metastasis
    Meeting Abstract

    Wijetunga, N. A.; Goglia, A.; Weinhold, N.; Cislo, M.; Berger, M.; Osman, A.; Pentsova, E.; Miller, A.; Powell, S. N.; Boire, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Phase II randomized trial comparing proton craniospinal irradiation with photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis
    Meeting Abstract

    Yang, J. T.; Wijetunga, N. A.; Pentsova, E.; Wolden, S. L.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Betof Warner, A.; Yu, H.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save